# A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors

> **NCT06158477** · PHASE1 · RECRUITING · sponsor: **Chengdu JOYO pharma Co., Ltd.** · enrollment: 75 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** JYP0035 Experimental Drug Treatment

## Key facts

- **NCT ID:** NCT06158477
- **Lead sponsor:** Chengdu JOYO pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06158477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06158477, "A Clinical Trial Evaluating JYP0035 Capsule Monotherapy in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06158477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*